The hepatitis A vaccine provides excellent, long-lasting protection — with a single initial dose offering immunity for approximately one year, and a booster dose given six to twelve months later extending that protection to at least 20–25 years and potentially for life in most healthy adults. Mathematical modelling based on antibody decay rates suggests that immunity following the two-dose course may in fact last considerably longer than 25 years — possibly lifelong — though long-term data beyond this point remains limited. The vaccine is highly effective, with clinical studies demonstrating a protection rate of over 95% against hepatitis A infection following the primary dose, rising to close to 100% after the booster. At Edinburgh Travel Clinic, our specialist travel health nurses review your vaccination history and travel plans to confirm whether your hepatitis A protection is current and to administer any doses you may need before your trip.

A quick pre-travel consultation is all it takes to confirm whether your hepatitis A protection is current and to get any doses you need before departure.  Book a consultation with Edinburgh Travel Clinic today and leave knowing your vaccination is exactly where it needs to be.

Key Takeaways

  • A single dose of the hepatitis A vaccine provides protection for approximately one year, making it suitable for imminent travel.
  • A booster dose given six to twelve months after the first dose extends protection to at least 20–25 years and is likely lifelong.
  • The hepatitis A vaccine is over 95% effective after the first dose and close to 100% effective after the booster.
  • The vaccine is recommended for travel to many destinations across Asia, Africa, Central and South America, and Eastern Europe.
  • A combined hepatitis A and B vaccine (Twinrix) is available for those requiring protection against both infections.
  • The vaccine is not routinely available on the NHS for travel purposes and is typically obtained through a private travel health clinic.

 

The Importance of Hepatitis A Vaccination

Hepatitis A is a highly contagious viral liver infection caused by the hepatitis A virus (HAV). Unlike hepatitis B and C, which are transmitted through blood and bodily fluids, hepatitis A spreads primarily through the faecal-oral route — meaning it is most commonly contracted through the consumption of food or water that has been contaminated with infected faecal matter. This makes it one of the most prevalent vaccine-preventable infections among international travellers, particularly those visiting destinations with lower standards of food hygiene and sanitation infrastructure.

The World Health Organization estimates that there are approximately 1.4 million cases of hepatitis A worldwide each year, though many cases go unreported due to mild or asymptomatic presentations. The disease ranges from a mild, self-limiting illness to a severe, prolonged condition with significant impact on daily life — and in rare cases it can cause acute liver failure, which can be fatal. Symptoms typically appear two to six weeks after exposure and include profound fatigue, nausea, abdominal pain, loss of appetite, dark urine, and jaundice (yellowing of the skin and eyes).

While most people recover fully from hepatitis A without lasting liver damage, the illness can be debilitating for weeks or even months — a significant consideration for anyone travelling for work, leisure, or family commitments. Older travellers and those with pre-existing liver conditions or chronic disease are at greater risk of severe illness. There is no specific antiviral treatment for hepatitis A, making prevention through vaccination the most effective strategy available.

How the Hepatitis A Vaccine Works

The hepatitis A vaccines available in the UK — including Havrix Monodose and Avaxim — are inactivated vaccines, meaning they contain killed hepatitis A virus particles that stimulate an immune response without causing infection. Following the initial dose, the immune system produces antibodies against the hepatitis A virus, with protective levels typically achieved within two weeks of vaccination in most healthy adults.

The good news for most healthy adults is that a single dose of the hepatitis A vaccine is all it takes to achieve protective immunity, with antibody levels reaching a protective threshold within two weeks of vaccination in the majority of recipients. If you are travelling imminently and have not yet been vaccinated, it is still worth getting your first dose as soon as possible — even partial protection is better than none, and the booster can be given on your return.

The duration of protection from the hepatitis A vaccine is one of its most reassuring features. A single initial dose is estimated to provide protection for approximately one year, which is sufficient for most short-term travel. The booster dose, administered six to twelve months after the first, triggers a powerful anamnestic (memory) immune response that dramatically elevates antibody levels and is estimated — based on mathematical modelling of antibody decay — to provide protection for at least 20–25 years and most likely for life in immunocompetent individuals.

It is worth noting that this long-term protection estimate is based on modelling rather than direct observational data extending beyond 25 years, simply because the vaccines have not been in use for long enough to generate that evidence. However, the scientific consensus among travel health and infectious disease specialists is that the two-dose course confers very long-lasting, if not lifelong, immunity in healthy adults — making it one of the most cost-effective travel vaccinations available.

person in white shirt receiving vaccine in arm

Hepatitis A Vaccine Options

Several hepatitis A vaccine options are available in the UK, including single-antigen vaccines and combined formulations that also protect against hepatitis B or typhoid. The table below outlines the key differences to help you understand your options before your consultation.

VaccineTypeProtects AgainstPrimary DoseBoosterDuration After BoosterMinimum Age
Havrix MonodoseSingleHepatitis A1 dose6–12 months later25+ years (likely lifelong)16 years
Havrix JuniorSingleHepatitis A1 dose6–12 months later25+ years (likely lifelong)1–15 years
AvaximSingleHepatitis A1 dose6–18 months later25+ years (likely lifelong)16 years
Twinrix AdultCombinedHepatitis A & B3 doses (0, 1, 6 months)Not routinely required25+ years (Hep A); long-term (Hep B)16 years
Twinrix PaediatricCombinedHepatitis A & B3 doses (0, 1, 6 months)Not routinely required25+ years (Hep A); long-term (Hep B)1–15 years
ViATIMCombinedHepatitis A & Typhoid1 doseHep A: 6–36 months
Typhoid: 3 years
25+ years (Hep A)16 years

Who Should Have the Hepatitis A Vaccine?

Hepatitis A vaccination is recommended for a wide range of travellers and is one of the most commonly administered travel vaccines in the UK. The primary indication for vaccination is travel to countries where hepatitis A is endemic and where food and water hygiene standards may not reliably prevent transmission.

High-risk destinations include much of sub-Saharan Africa, South and Southeast Asia, Central Asia, the Middle East, Central and South America, and parts of Eastern Europe. Even travellers staying in good quality accommodation should not assume they are at low risk — hepatitis A can be contracted from restaurant meals, buffet food, salads, shellfish, and locally sourced produce regardless of the standard of the establishment.

Beyond travellers, hepatitis A vaccination is also recommended for individuals with chronic liver disease (including those with hepatitis B or C), men who have sex with men, people who inject drugs, and those in close contact with a confirmed hepatitis A case. Healthcare workers and food handlers in high-risk occupational settings may also benefit from vaccination. These groups should discuss their individual circumstances with a healthcare professional to determine whether NHS-funded vaccination is available to them.

Do You Need a Booster If You Have Had the Hepatitis A Vaccine Before?

This is one of the most common questions asked at pre-travel consultations. The answer depends on how many doses you have received, when you received them, and whether the full two-dose course was completed.

If you received only the initial single dose of the hepatitis A vaccine and have not yet had the booster, your protection is likely to have waned if more than one to two years have elapsed since vaccination. In this case, a booster dose is recommended before travel to a hepatitis A-risk destination to restore full protection. Importantly, you do not need to restart the course from scratch — a single booster dose is sufficient regardless of how long ago the initial dose was given, as immunological memory is retained.

If you completed the full two-dose course (initial dose plus booster) at any point in your life, current evidence strongly suggests that you are likely to be protected for at least 20–25 years and possibly for life. A further booster dose is not routinely recommended for healthy adults who have completed the full course. However, individuals who are immunocompromised or who have chronic liver disease may have a reduced or less durable immune response and should seek specific advice from their clinician regarding the need for antibody titre testing or additional doses.

If you are unsure of your vaccination history, Edinburgh Travel Clinic can help you check your records and advise on the most appropriate course of action. In some cases, a blood test to check for hepatitis A antibodies can confirm whether protection is present, though in practice it is often more straightforward — and equally cost-effective — to simply administer a booster dose.

Whether you need a first dose, a booster, or simply a review of your vaccination history, Edinburgh Travel Clinic is here to make the process straightforward.  Call us to book a consultation today and travel with complete confidence.

Hepatitis A Vaccine Safety and Suitability

The hepatitis A vaccine has an excellent safety profile and is one of the most well-tolerated travel vaccines available. It is an inactivated vaccine, meaning it contains no live virus and cannot cause hepatitis A infection under any circumstances.

The most commonly reported side effects are mild and localised, including soreness, redness, and swelling at the injection site. These typically resolve within a day or two without any intervention. Systemic reactions such as mild headache, fatigue, and low-grade fever are reported less frequently and are generally short-lived. Serious adverse reactions are rare.

The hepatitis A vaccine is considered safe for use during pregnancy and breastfeeding when the benefits of vaccination outweigh the risks of potential exposure — as an inactivated vaccine, it carries no theoretical risk of live virus transmission. It is also suitable for immunocompromised individuals, though the immune response may be reduced in this group and antibody testing may be recommended to confirm protection. The vaccine is licensed for use in children from one year of age.

As with all vaccines, a pre-vaccination health check is carried out before each dose to confirm suitability. The only absolute contraindication to the hepatitis A vaccine is a known severe hypersensitivity (anaphylaxis) to any component of the vaccine, including residual traces of neomycin in some formulations.

Hepatitis A and Food Safety

A question that often arises in travel health consultations is whether careful food and water hygiene is sufficient to prevent hepatitis A without vaccination. The honest answer is: it helps significantly, but it cannot reliably replace vaccination for travellers to endemic areas.

The principle of “boil it, cook it, peel it, or forget it” is a well-established travel health guideline that reduces — but does not eliminate — the risk of hepatitis A and other enteric infections. The challenge with hepatitis A specifically is that the virus is environmentally resilient, surviving on surfaces and in food for extended periods, and that even scrupulous hygiene cannot account for contamination that occurs earlier in the food supply chain before the traveller has any influence over it.

Shellfish — particularly raw or lightly cooked oysters, clams, and mussels — are a well-documented source of hepatitis A exposure, as they filter large volumes of water and can concentrate the virus from contaminated water sources. Salads, unpeeled fruit, and ice made from untreated water are additional common sources of exposure for travellers. Vaccination removes the need to worry about any of these risks, providing robust background protection that allows travellers to engage more freely and confidently with local food culture — one of the great joys of international travel.

Vaccination is the single most reliable way to protect yourself against hepatitis A when travelling to endemic areas and Edinburgh Travel Clinic makes getting vaccinated quick, easy, and expert-led.  Contact us to book a consultation today.

plane flying in blue sky with clouds in the background

Frequently Asked Questions

We have answered the hepatitis A vaccine questions our travellers ask us most often below and our specialist team is always on hand if you need more personalised advice.

Is the hepatitis A vaccine available on the NHS?

The hepatitis A vaccine is not routinely available on the NHS for travel purposes and is typically obtained privately through a travel health clinic such as Edinburgh Travel Clinic. It is available on the NHS for certain high-risk groups including those with chronic liver disease, men who have sex with men, and people who inject drugs — speak to your GP if you believe you may qualify for NHS-funded vaccination.

How soon before travel should I have the hepatitis A vaccine?

Ideally, the hepatitis A vaccine should be given at least two weeks before travel to allow full protective antibody levels to develop, though even a dose given on the day of departure provides some degree of protection and is better than no vaccination at all. If you are travelling imminently, Edinburgh Travel Clinic can advise on the best approach given your departure date and destination.

Can I have the hepatitis A vaccine if I am already immune due to a past infection?

If you have previously had hepatitis A infection, you are likely to have developed natural immunity and the vaccine would not be necessary — though vaccination in someone with existing immunity is not harmful. If you are unsure whether you have had hepatitis A in the past, a blood test to check for hepatitis A antibodies can confirm your immune status before vaccination.

Can children have the hepatitis A vaccine?

Yes — the hepatitis A vaccine is licensed for use in children from one year of age, with a paediatric formulation (Havrix Junior) available for children aged one to fifteen years. Children travelling to hepatitis A-risk destinations should receive the vaccine on the same two-dose schedule as adults, with the booster given six to twelve months after the initial dose.

If I only had one dose years ago, do I need to start again?

No — if you received the initial dose of the hepatitis A vaccine at any point in the past, you do not need to restart the course, as immunological memory is retained even after many years. A single booster dose is all that is needed to restore full, long-lasting protection regardless of how long ago the first dose was given.

Is the hepatitis A vaccine the same as the hepatitis B vaccine?

No — hepatitis A and hepatitis B are caused by entirely different viruses, are transmitted differently, and require separate vaccines, though a combined vaccine (Twinrix) is available that protects against both infections in a single course. Your travel health clinician can advise on whether the combined vaccine is the most appropriate option for your destination and health profile.

Long-Lasting Protection Against Hepatitis A

The hepatitis A vaccine is one of the most effective, well-tolerated, and long-lasting travel vaccines available — and with a two-dose course potentially providing lifelong protection, it represents an outstanding investment in your long-term travel health. Whether you are travelling for the first time or returning to a destination you have visited before, checking your hepatitis A vaccination status before you go is a simple and highly effective step towards protecting your health abroad.

At Edinburgh Travel Clinic, we are here to make the process easy. Our specialist travel health team will review your vaccination history, confirm which doses you need, and administer them promptly alongside any other travel health advice relevant to your destination. Whether you need a first dose before an imminent departure, a long-overdue booster, or a full course for a first-time trip to a high-risk destination, we have you covered. Book now and set off on your next adventure knowing your hepatitis A protection is exactly where it needs to be.

Disclaimer: The information provided in this blog post is intended for general informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional or travel health specialist before beginning any vaccination course, treatment, or preventative health regimen. Individual health circumstances, medical history, and destination-specific risks vary — Edinburgh Travel Clinic’s specialist team is available to provide personalised guidance tailored to your individual needs and travel plans.
☑ Clinically Reviewed by Pharmacy Mentor
A pharmacist reviews the content to help ensure medicines are presented responsibly and that patient facing health information is accurate, appropriate, and aligned with current clinical guidance.
Last reviewed: 5 August 2026
Written on behalf of Edinburgh Travel Clinic by Pharmacy Mentor.